Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NADIR: Niraparib with Radiotherapy and ADT in High Risk Prostate Cancer
NCT04037254Phase 2Completed
- Sponsor
- NRG Oncology
- Start
- Oct 2019
- Primary completion
- Jul 2024
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of niraparib in prostate cancer (PCa), sponsored by NRG Oncology. Started Oct 2019; status: completed.
02
Drugs
niraparib
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT04037254.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04037254.